Abstract
The X-linked lymphoproliferative disease (XLP), one of six described X-linked immunodeficiencies, stems from a mutation at Xq25 which renders males impotent to mount an effective immune response to the ubiquitous EBV. Purtilo, who first observed this disease in 1969, established a Registry in 1980 to serve as a worldwide resource for the diagnosis, treatment, and research of this condition. Since Purtilo's death in late 1992, the Registry and research unit have not only continued to function as a worldwide consultative service, but have contributed the following. First, the number of affected boys has continued to grow; some 272 among 80 kindreds have been identified. Second, some boys (10%) who inherit the mutated XLP gene are immunologically abnormal even before evidence of EBV exposure. Third, the search for the XLP gene has been narrowed to a small region on Xq25. Its identification is near at hand; once cloned, this gene may well illustrate how the body orchestrates the complex immune response to EBV. Therein lies the justification for the quest for this gene, not only for the benefit of the few surviving boys and those to be born to female carriers, but also for defining its role in defending the body against a ubiquitous DNA virus.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seemayer, T., Gross, T., Egeler, R. et al. X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery. Pediatr Res 38, 471–478 (1995). https://doi.org/10.1203/00006450-199510000-00001
Issue Date:
DOI: https://doi.org/10.1203/00006450-199510000-00001
This article is cited by
-
The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity
Journal of Clinical Immunology (2022)
-
X-linked Lymphoproliferative Disease (XLP1) Presenting as Non-Epstein Barr Virus (EBV) — Related Hemophagocytic Lymphohistiocytosis (HLH)
Indian Pediatrics (2020)
-
X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic
European Journal of Pediatrics (2020)